BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Investor Lawsuit over Certain Statements Concerning LibiGel’s Efficacy Trial Results
A lawsuit was filed by an investor in shares of BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) over alleged securities laws violations in connection with LibiGel efficacy trial results. Deadline: April 6, 2012 and NASDAQ:BPAX) stockholders should contact the Shareholders Foundation.
View full press release